Mersana Therapeutics Inc
General ticker "MRSN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $268.5M
Mersana Therapeutics Inc does not follow the US Stock Market performance with the rate: -12.0%.
Estimated limits based on current volatility of 7.7%: low 1.43$, high 1.67$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.07$, 3.60$]
- 2024-12-30 to 2025-12-30 estimated range: [1.13$, 3.67$]
Financial Metrics affecting the MRSN estimates:
- Negative: Non-GAAP EPS, $ of -1.50 <= 0.10
- Negative: Operating profit margin, % of -82.27 <= 1.03
- Negative: Operating cash flow per share per price, % of -42.82 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0.04 <= 0.14
Short-term MRSN quotes
Long-term MRSN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $29.02MM | $36.85MM |
| Operating Expenses | $171.26MM | $233.68MM | $207.81MM |
| Operating Income | $-171.26MM | $-204.66MM | $-170.96MM |
| Non-Operating Income | $0.00MM | $0.00MM | $7.29MM |
| Interest Expense | $1.27MM | $3.33MM | $4.07MM |
| R&D Expense | $132.01MM | $173.38MM | $148.27MM |
| Income(Loss) | $-171.26MM | $-204.66MM | $-163.67MM |
| Profit(Loss) | $-171.26MM | $-204.66MM | $-163.67MM |
| Stockholders Equity | $121.74MM | $92.06MM | $36.90MM |
| Assets | $206.11MM | $334.34MM | $226.06MM |
| Operating Cash Flow | $-139.99MM | $-49.36MM | $-168.88MM |
| Capital expenditure | $0.65MM | $2.20MM | $2.17MM |
| Investing Cash Flow | $-0.65MM | $-152.72MM | $119.88MM |
| Financing Cash Flow | $63.65MM | $153.02MM | $94.67MM |
| Earnings Per Share* | $-2.40 | $-2.22 | $-1.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.